

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.94004134 |
| 2 | negative T cell selection (GO:0043383) | 6.78739505 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.64785089 |
| 4 | negative regulation of cell killing (GO:0031342) | 6.64785089 |
| 5 | negative thymic T cell selection (GO:0045060) | 6.55319626 |
| 6 | positive thymic T cell selection (GO:0045059) | 5.88096744 |
| 7 | positive T cell selection (GO:0043368) | 5.58281142 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.45044230 |
| 9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.39242777 |
| 10 | thymic T cell selection (GO:0045061) | 5.36441879 |
| 11 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.25711391 |
| 12 | T cell selection (GO:0045058) | 5.17455517 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 5.12190737 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.04543537 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.04543537 |
| 16 | leukocyte aggregation (GO:0070486) | 5.01388013 |
| 17 | response to interleukin-15 (GO:0070672) | 4.95626364 |
| 18 | interferon-gamma production (GO:0032609) | 4.91886726 |
| 19 | cellular response to interleukin-15 (GO:0071350) | 4.90891097 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.63922730 |
| 21 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.63140373 |
| 22 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.60948974 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.56243214 |
| 24 | positive regulation of granulocyte differentiation (GO:0030854) | 4.50895704 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.50287061 |
| 26 | T cell migration (GO:0072678) | 4.32086766 |
| 27 | establishment of protein localization to Golgi (GO:0072600) | 4.26720777 |
| 28 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.18681613 |
| 29 | regulation of T cell tolerance induction (GO:0002664) | 4.11473025 |
| 30 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.10787348 |
| 31 | protein targeting to Golgi (GO:0000042) | 4.09068962 |
| 32 | positive regulation of isotype switching (GO:0045830) | 4.02710744 |
| 33 | regulation of regulatory T cell differentiation (GO:0045589) | 3.99780908 |
| 34 | T cell receptor signaling pathway (GO:0050852) | 3.98523102 |
| 35 | tolerance induction (GO:0002507) | 3.97780967 |
| 36 | lymphocyte costimulation (GO:0031294) | 3.90888492 |
| 37 | T cell costimulation (GO:0031295) | 3.88739839 |
| 38 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.87270882 |
| 39 | histone H3-K36 demethylation (GO:0070544) | 3.80007448 |
| 40 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.78379588 |
| 41 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.77571654 |
| 42 | negative regulation of T cell mediated immunity (GO:0002710) | 3.70965422 |
| 43 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.70348931 |
| 44 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.65840911 |
| 45 | positive regulation of interleukin-2 production (GO:0032743) | 3.60630586 |
| 46 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.59999577 |
| 47 | regulation of isotype switching (GO:0045191) | 3.58793459 |
| 48 | positive regulation of DNA recombination (GO:0045911) | 3.58659740 |
| 49 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.58642672 |
| 50 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.55027841 |
| 51 | positive regulation of humoral immune response (GO:0002922) | 3.48118782 |
| 52 | regulation of B cell differentiation (GO:0045577) | 3.47366099 |
| 53 | protein K11-linked deubiquitination (GO:0035871) | 3.47335900 |
| 54 | B cell receptor signaling pathway (GO:0050853) | 3.46767942 |
| 55 | histone mRNA catabolic process (GO:0071044) | 3.41867770 |
| 56 | peptidyl-lysine trimethylation (GO:0018023) | 3.33117792 |
| 57 | alpha-beta T cell activation (GO:0046631) | 3.28985396 |
| 58 | protein K48-linked deubiquitination (GO:0071108) | 3.28585299 |
| 59 | interkinetic nuclear migration (GO:0022027) | 3.27547568 |
| 60 | NIK/NF-kappaB signaling (GO:0038061) | 3.26933013 |
| 61 | T-helper cell differentiation (GO:0042093) | 3.25205749 |
| 62 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.25205749 |
| 63 | positive regulation of B cell mediated immunity (GO:0002714) | 3.23161495 |
| 64 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.23161495 |
| 65 | histone H3-K4 trimethylation (GO:0080182) | 3.19844089 |
| 66 | alpha-beta T cell differentiation (GO:0046632) | 3.18242700 |
| 67 | positive regulation of tolerance induction (GO:0002645) | 3.14537309 |
| 68 | T cell differentiation (GO:0030217) | 3.10652857 |
| 69 | leukocyte cell-cell adhesion (GO:0007159) | 3.09295464 |
| 70 | neural tube formation (GO:0001841) | 3.08622892 |
| 71 | nuclear pore complex assembly (GO:0051292) | 3.07730192 |
| 72 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.04315387 |
| 73 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.04287549 |
| 74 | natural killer cell activation (GO:0030101) | 3.03823731 |
| 75 | regulation of B cell mediated immunity (GO:0002712) | 3.03533033 |
| 76 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.02815740 |
| 77 | T cell homeostasis (GO:0043029) | 3.01932652 |
| 78 | myeloid dendritic cell activation (GO:0001773) | 3.01776789 |
| 79 | histone H3-K9 modification (GO:0061647) | 3.01286459 |
| 80 | regulation of tolerance induction (GO:0002643) | 3.00030188 |
| 81 | positive regulation of immunoglobulin production (GO:0002639) | 2.99278212 |
| 82 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.98786029 |
| 83 | positive regulation of B cell differentiation (GO:0045579) | 2.95213609 |
| 84 | mast cell activation involved in immune response (GO:0002279) | 2.94643613 |
| 85 | mast cell degranulation (GO:0043303) | 2.94643613 |
| 86 | regulation of immunoglobulin production (GO:0002637) | 2.93493652 |
| 87 | activated T cell proliferation (GO:0050798) | 2.93136623 |
| 88 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.92574009 |
| 89 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.92574009 |
| 90 | T cell differentiation involved in immune response (GO:0002292) | 2.92574009 |
| 91 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.92324580 |
| 92 | regulation of granulocyte differentiation (GO:0030852) | 2.90523394 |
| 93 | mast cell activation (GO:0045576) | 2.89365020 |
| 94 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.87681074 |
| 95 | pore complex assembly (GO:0046931) | 2.87608999 |
| 96 | histone H3-K9 methylation (GO:0051567) | 2.87167165 |
| 97 | angiogenesis involved in wound healing (GO:0060055) | 2.85441546 |
| 98 | positive regulation of B cell proliferation (GO:0030890) | 2.85368772 |
| 99 | regulation of B cell proliferation (GO:0030888) | 2.84658507 |
| 100 | B cell proliferation (GO:0042100) | 2.83128837 |
| 101 | lymphocyte homeostasis (GO:0002260) | 2.82918133 |
| 102 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.82346505 |
| 103 | T cell proliferation (GO:0042098) | 2.81713611 |
| 104 | negative regulation of phagocytosis (GO:0050765) | 2.81305497 |
| 105 | T cell activation (GO:0042110) | 2.80543338 |
| 106 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.79014233 |
| 107 | regulation of response to interferon-gamma (GO:0060330) | 2.78078203 |
| 108 | B cell homeostasis (GO:0001782) | 2.78035701 |
| 109 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.77047008 |
| 110 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.77047008 |
| 111 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.76774150 |
| 112 | cellular response to ethanol (GO:0071361) | 2.75938916 |
| 113 | protein K63-linked deubiquitination (GO:0070536) | 2.75287129 |
| 114 | dosage compensation (GO:0007549) | 2.75032840 |
| 115 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.75016554 |
| 116 | negative regulation of adaptive immune response (GO:0002820) | 2.74388739 |
| 117 | regulation of interleukin-2 production (GO:0032663) | 2.73190477 |
| 118 | regulation of alpha-beta T cell activation (GO:0046634) | 2.72918044 |
| 119 | positive regulation of B cell activation (GO:0050871) | 2.72426851 |
| 120 | hepatocyte apoptotic process (GO:0097284) | 2.72271139 |
| 121 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.72079108 |
| 122 | protein localization to Golgi apparatus (GO:0034067) | 2.71367770 |
| 123 | T cell lineage commitment (GO:0002360) | 2.71232128 |
| 124 | regulation of chronic inflammatory response (GO:0002676) | 2.70695429 |
| 125 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.70541048 |
| 126 | Peyers patch development (GO:0048541) | 2.70315285 |
| 127 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.70315285 |
| 128 | negative regulation of B cell proliferation (GO:0030889) | 2.70169306 |
| 129 | cellular extravasation (GO:0045123) | 2.68947366 |
| 130 | rRNA catabolic process (GO:0016075) | 2.68847546 |
| 131 | T cell activation involved in immune response (GO:0002286) | 2.68152734 |
| 132 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.68039951 |
| 133 | regulation of cell killing (GO:0031341) | 2.67050715 |
| 134 | histone H3-K4 methylation (GO:0051568) | 2.65248481 |
| 135 | regulation of fibroblast apoptotic process (GO:2000269) | 2.64909044 |
| 136 | histone lysine demethylation (GO:0070076) | 2.64673168 |
| 137 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.63291486 |
| 138 | positive regulation of mRNA catabolic process (GO:0061014) | 2.61740341 |
| 139 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.61362518 |
| 140 | microtubule nucleation (GO:0007020) | 2.61357167 |
| 141 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.60741754 |
| 142 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.60741754 |
| 143 | nuclear pore organization (GO:0006999) | 2.60682176 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.23718342 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.26696439 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.14228047 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.44970851 |
| 5 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.95537799 |
| 6 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.73135055 |
| 7 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.54520916 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.54125199 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.45988991 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.18548808 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.16815548 |
| 12 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.07783192 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 3.06507761 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.77692560 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.73517459 |
| 16 | * MYB_26560356_Chip-Seq_TH1_Human | 2.68069293 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.63706871 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.51601629 |
| 19 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.47402900 |
| 20 | MAF_26560356_Chip-Seq_TH1_Human | 2.46822401 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34678747 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.34124415 |
| 23 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.30395808 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.27703414 |
| 25 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.27101087 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.22339378 |
| 27 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.21254951 |
| 28 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.16716850 |
| 29 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.10085183 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08821064 |
| 31 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.08182726 |
| 32 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.99719954 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.96464045 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.93514756 |
| 35 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.91967383 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.91680024 |
| 37 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.89588643 |
| 38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.86346738 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.85650135 |
| 40 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.83483428 |
| 41 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.81220706 |
| 42 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.79257957 |
| 43 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.75843971 |
| 44 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.73027316 |
| 45 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.72865290 |
| 46 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.72385009 |
| 47 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.67668356 |
| 48 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.66968049 |
| 49 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.66875025 |
| 50 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63100298 |
| 51 | MAF_26560356_Chip-Seq_TH2_Human | 1.60666893 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.58203127 |
| 53 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.56488795 |
| 54 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54763768 |
| 55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.53040140 |
| 56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49734021 |
| 57 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.49020101 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48866086 |
| 59 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.46063685 |
| 60 | FUS_26573619_Chip-Seq_HEK293_Human | 1.44481507 |
| 61 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40346960 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40299214 |
| 63 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.33567691 |
| 64 | VDR_22108803_ChIP-Seq_LS180_Human | 1.33313179 |
| 65 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.33215838 |
| 66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.28103851 |
| 67 | TP53_16413492_ChIP-PET_HCT116_Human | 1.27526980 |
| 68 | EWS_26573619_Chip-Seq_HEK293_Human | 1.27107408 |
| 69 | TCF4_23295773_ChIP-Seq_U87_Human | 1.25852294 |
| 70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.25815954 |
| 71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25266511 |
| 72 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.24998168 |
| 73 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.24998168 |
| 74 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.24305378 |
| 75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.23867199 |
| 76 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.23502015 |
| 77 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.22377293 |
| 78 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19505485 |
| 79 | P300_19829295_ChIP-Seq_ESCs_Human | 1.19349458 |
| 80 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.18954301 |
| 81 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18545685 |
| 82 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.18090150 |
| 83 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17975338 |
| 84 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.17463851 |
| 85 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15834462 |
| 86 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.15249485 |
| 87 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.15164249 |
| 88 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13536005 |
| 89 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.13482255 |
| 90 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.12766089 |
| 91 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11994258 |
| 92 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11994258 |
| 93 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.11664466 |
| 94 | * AR_21572438_ChIP-Seq_LNCaP_Human | 1.08342901 |
| 95 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.07912021 |
| 96 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.07864965 |
| 97 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.05667105 |
| 98 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.05574837 |
| 99 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.05393177 |
| 100 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.02984633 |
| 101 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01867539 |
| 102 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01318151 |
| 103 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.00611723 |
| 104 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00507680 |
| 105 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00102273 |
| 106 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.99970052 |
| 107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98426629 |
| 108 | GATA3_26560356_Chip-Seq_TH1_Human | 0.98421888 |
| 109 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.98200458 |
| 110 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.97689170 |
| 111 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96311520 |
| 112 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95645228 |
| 113 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.95070256 |
| 114 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94934181 |
| 115 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 0.93274046 |
| 116 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93157634 |
| 117 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92576759 |
| 118 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.90806822 |
| 119 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90469300 |
| 120 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.90030171 |
| 121 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90017741 |
| 122 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.89061442 |
| 123 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88688724 |
| 124 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.88455388 |
| 125 | KDM2B_26808549_Chip-Seq_REH_Human | 0.87986571 |
| 126 | * TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87394167 |
| 127 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.87264256 |
| 128 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.86788106 |
| 129 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.86621111 |
| 130 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.85660243 |
| 131 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.85353304 |
| 132 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85346238 |
| 133 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79700620 |
| 134 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.75394947 |
| 135 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73555056 |
| 136 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.73421554 |
| 137 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.73074899 |
| 138 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72555073 |
| 139 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72327985 |
| 140 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.70013015 |
| 141 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.68853347 |
| 142 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.68220997 |
| 143 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.67738995 |
| 144 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.66337272 |
| 145 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.65896476 |
| 146 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.65640962 |
| 147 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.64945246 |
| 148 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.64480709 |
| 149 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.63349440 |
| 150 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.63216002 |
| 151 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.63098317 |
| 152 | * ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.62839425 |
| 153 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.62011373 |
| 154 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.61900763 |
| 155 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.60925690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.65909703 |
| 2 | MP0005671_abnormal_response_to | 3.89047073 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.58517623 |
| 4 | MP0002166_altered_tumor_susceptibility | 3.36889360 |
| 5 | MP0000685_abnormal_immune_system | 3.21136420 |
| 6 | MP0001800_abnormal_humoral_immune | 3.10089030 |
| 7 | MP0005387_immune_system_phenotype | 3.00540139 |
| 8 | MP0001790_abnormal_immune_system | 3.00540139 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.85087900 |
| 10 | MP0002006_tumorigenesis | 2.81425393 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.69366103 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.67566313 |
| 13 | MP0002398_abnormal_bone_marrow | 2.64567390 |
| 14 | MP0001819_abnormal_immune_cell | 2.63456310 |
| 15 | MP0002723_abnormal_immune_serum | 2.61292232 |
| 16 | MP0001873_stomach_inflammation | 2.58462028 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.58179938 |
| 18 | MP0002009_preneoplasia | 2.57767528 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.43662321 |
| 20 | MP0009785_altered_susceptibility_to | 2.38898705 |
| 21 | MP0003436_decreased_susceptibility_to | 2.35946125 |
| 22 | MP0000703_abnormal_thymus_morphology | 2.32361281 |
| 23 | MP0003303_peritoneal_inflammation | 2.29953512 |
| 24 | MP0002405_respiratory_system_inflammati | 2.27994738 |
| 25 | MP0000716_abnormal_immune_system | 2.26771407 |
| 26 | MP0005025_abnormal_response_to | 2.14136656 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 2.09276376 |
| 28 | MP0004808_abnormal_hematopoietic_stem | 2.06001454 |
| 29 | * MP0002722_abnormal_immune_system | 2.04181158 |
| 30 | * MP0000689_abnormal_spleen_morphology | 2.02352491 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.98655685 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.96331019 |
| 33 | MP0008057_abnormal_DNA_replication | 1.92965497 |
| 34 | MP0002419_abnormal_innate_immunity | 1.92138829 |
| 35 | MP0003866_abnormal_defecation | 1.86827752 |
| 36 | MP0002429_abnormal_blood_cell | 1.84131838 |
| 37 | MP0001853_heart_inflammation | 1.82758108 |
| 38 | MP0005310_abnormal_salivary_gland | 1.82213910 |
| 39 | MP0006082_CNS_inflammation | 1.81626211 |
| 40 | MP0000569_abnormal_digit_pigmentation | 1.78335102 |
| 41 | MP0004510_myositis | 1.71972689 |
| 42 | MP0003724_increased_susceptibility_to | 1.69376950 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.62349377 |
| 44 | MP0004947_skin_inflammation | 1.58853866 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.51246060 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.50000715 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.50000715 |
| 48 | MP0008961_abnormal_basal_metabolism | 1.46972614 |
| 49 | MP0002933_joint_inflammation | 1.46151646 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.42327455 |
| 51 | MP0003656_abnormal_erythrocyte_physiolo | 1.32910784 |
| 52 | MP0010352_gastrointestinal_tract_polyps | 1.32778371 |
| 53 | MP0000490_abnormal_crypts_of | 1.29102154 |
| 54 | MP0010094_abnormal_chromosome_stability | 1.27598424 |
| 55 | MP0001851_eye_inflammation | 1.27254575 |
| 56 | MP0003221_abnormal_cardiomyocyte_apopto | 1.20974068 |
| 57 | MP0001348_abnormal_lacrimal_gland | 1.20770458 |
| 58 | MP0000427_abnormal_hair_cycle | 1.17118037 |
| 59 | MP0003077_abnormal_cell_cycle | 1.16242042 |
| 60 | MP0003787_abnormal_imprinting | 1.13803392 |
| 61 | MP0001986_abnormal_taste_sensitivity | 1.13354321 |
| 62 | MP0005174_abnormal_tail_pigmentation | 1.10513715 |
| 63 | MP0000858_altered_metastatic_potential | 1.07577959 |
| 64 | MP0008995_early_reproductive_senescence | 1.06210319 |
| 65 | MP0002102_abnormal_ear_morphology | 1.06028835 |
| 66 | MP0004130_abnormal_muscle_cell | 1.04508828 |
| 67 | MP0005083_abnormal_biliary_tract | 1.04309764 |
| 68 | MP0003045_fibrosis | 1.04262274 |
| 69 | MP0000015_abnormal_ear_pigmentation | 1.03516195 |
| 70 | MP0003448_altered_tumor_morphology | 1.01438895 |
| 71 | MP0002019_abnormal_tumor_incidence | 1.01255270 |
| 72 | MP0009278_abnormal_bone_marrow | 0.98491379 |
| 73 | MP0001533_abnormal_skeleton_physiology | 0.97905389 |
| 74 | MP0008877_abnormal_DNA_methylation | 0.95247354 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 0.90818682 |
| 76 | MP0008058_abnormal_DNA_repair | 0.90179199 |
| 77 | MP0010307_abnormal_tumor_latency | 0.89633838 |
| 78 | MP0008007_abnormal_cellular_replicative | 0.88086730 |
| 79 | MP0002095_abnormal_skin_pigmentation | 0.88038855 |
| 80 | MP0001919_abnormal_reproductive_system | 0.87523195 |
| 81 | MP0005076_abnormal_cell_differentiation | 0.85384866 |
| 82 | MP0003111_abnormal_nucleus_morphology | 0.85351590 |
| 83 | MP0005023_abnormal_wound_healing | 0.84854654 |
| 84 | MP0003693_abnormal_embryo_hatching | 0.82143811 |
| 85 | MP0003121_genomic_imprinting | 0.81550140 |
| 86 | MP0003890_abnormal_embryonic-extraembry | 0.81185426 |
| 87 | MP0008469_abnormal_protein_level | 0.80096187 |
| 88 | MP0005423_abnormal_somatic_nervous | 0.79952344 |
| 89 | MP0004142_abnormal_muscle_tone | 0.78742486 |
| 90 | MP0002928_abnormal_bile_duct | 0.77344278 |
| 91 | MP0003183_abnormal_peptide_metabolism | 0.75742202 |
| 92 | MP0002138_abnormal_hepatobiliary_system | 0.75071976 |
| 93 | MP0004381_abnormal_hair_follicle | 0.74741902 |
| 94 | MP0003880_abnormal_central_pattern | 0.74482171 |
| 95 | MP0003828_pulmonary_edema | 0.74127742 |
| 96 | MP0004883_abnormal_blood_vessel | 0.72866879 |
| 97 | MP0005410_abnormal_fertilization | 0.72748948 |
| 98 | MP0002998_abnormal_bone_remodeling | 0.71812686 |
| 99 | MP0005551_abnormal_eye_electrophysiolog | 0.71171551 |
| 100 | MP0001929_abnormal_gametogenesis | 0.71027450 |
| 101 | MP0005084_abnormal_gallbladder_morpholo | 0.70925231 |
| 102 | MP0003091_abnormal_cell_migration | 0.70126117 |
| 103 | MP0005253_abnormal_eye_physiology | 0.69857526 |
| 104 | MP0005645_abnormal_hypothalamus_physiol | 0.67672648 |
| 105 | MP0009115_abnormal_fat_cell | 0.67557589 |
| 106 | MP0005386_behavior/neurological_phenoty | 0.66626593 |
| 107 | MP0004924_abnormal_behavior | 0.66626593 |
| 108 | MP0003690_abnormal_glial_cell | 0.66475463 |
| 109 | MP0004484_altered_response_of | 0.64264021 |
| 110 | MP0004742_abnormal_vestibular_system | 0.63378401 |
| 111 | MP0003943_abnormal_hepatobiliary_system | 0.62218815 |
| 112 | MP0003646_muscle_fatigue | 0.61525586 |
| 113 | MP0000371_diluted_coat_color | 0.61384621 |
| 114 | MP0005389_reproductive_system_phenotype | 0.60263095 |
| 115 | MP0003698_abnormal_male_reproductive | 0.60177793 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.60089065 |
| 117 | MP0002638_abnormal_pupillary_reflex | 0.59934548 |
| 118 | MP0001501_abnormal_sleep_pattern | 0.59517698 |
| 119 | MP0006054_spinal_hemorrhage | 0.59145583 |
| 120 | MP0005379_endocrine/exocrine_gland_phen | 0.58606473 |
| 121 | MP0003786_premature_aging | 0.58531640 |
| 122 | MP0005266_abnormal_metabolism | 0.57905685 |
| 123 | MP0009764_decreased_sensitivity_to | 0.56671354 |
| 124 | MP0002822_catalepsy | 0.56637821 |
| 125 | MP0005409_darkened_coat_color | 0.54661603 |
| 126 | MP0000249_abnormal_blood_vessel | 0.53782720 |
| 127 | MP0002163_abnormal_gland_morphology | 0.53557988 |
| 128 | MP0000313_abnormal_cell_death | 0.52317503 |
| 129 | MP0000350_abnormal_cell_proliferation | 0.50884003 |
| 130 | MP0003453_abnormal_keratinocyte_physiol | 0.50128180 |
| 131 | MP0002132_abnormal_respiratory_system | 0.49789024 |
| 132 | MP0004957_abnormal_blastocyst_morpholog | 0.47629042 |
| 133 | MP0001663_abnormal_digestive_system | 0.46656722 |
| 134 | MP0009763_increased_sensitivity_to | 0.46385591 |
| 135 | MP0002086_abnormal_extraembryonic_tissu | 0.42864552 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.71244210 |
| 2 | Abnormality of T cell number (HP:0011839) | 5.61104045 |
| 3 | Abnormality of the fingertips (HP:0001211) | 4.30427176 |
| 4 | Recurrent fungal infections (HP:0002841) | 4.30208941 |
| 5 | Recurrent viral infections (HP:0004429) | 4.21618597 |
| 6 | Abnormality of T cells (HP:0002843) | 4.19603579 |
| 7 | Recurrent bronchitis (HP:0002837) | 4.07352473 |
| 8 | Severe combined immunodeficiency (HP:0004430) | 4.03415148 |
| 9 | IgM deficiency (HP:0002850) | 3.85842171 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.76482232 |
| 11 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.73887842 |
| 12 | Recurrent cutaneous fungal infections (HP:0011370) | 3.73887842 |
| 13 | Myositis (HP:0100614) | 3.66990185 |
| 14 | Combined immunodeficiency (HP:0005387) | 3.64426199 |
| 15 | Thyroiditis (HP:0100646) | 3.63317973 |
| 16 | Eczematoid dermatitis (HP:0000976) | 3.59780456 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 3.59234989 |
| 18 | Abnormality of B cell number (HP:0010975) | 3.57013530 |
| 19 | B lymphocytopenia (HP:0010976) | 3.57013530 |
| 20 | Stomatitis (HP:0010280) | 3.55948214 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 3.48171939 |
| 22 | Optic neuritis (HP:0100653) | 3.48171939 |
| 23 | Chronic diarrhea (HP:0002028) | 3.48023538 |
| 24 | IgG deficiency (HP:0004315) | 3.42298187 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.39595017 |
| 26 | Nasal polyposis (HP:0100582) | 3.31346422 |
| 27 | Stomach cancer (HP:0012126) | 3.30917408 |
| 28 | Autoimmune hemolytic anemia (HP:0001890) | 3.20319824 |
| 29 | Agammaglobulinemia (HP:0004432) | 3.20239434 |
| 30 | Autoimmune thrombocytopenia (HP:0001973) | 3.16737891 |
| 31 | Lymphopenia (HP:0001888) | 3.14225775 |
| 32 | Abnormality of eosinophils (HP:0001879) | 3.10754373 |
| 33 | IgA deficiency (HP:0002720) | 3.08860525 |
| 34 | Recurrent abscess formation (HP:0002722) | 3.08790132 |
| 35 | Chronic otitis media (HP:0000389) | 3.07835961 |
| 36 | Eosinophilia (HP:0001880) | 3.06490026 |
| 37 | Meningitis (HP:0001287) | 3.04680560 |
| 38 | Genetic anticipation (HP:0003743) | 3.04390961 |
| 39 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.03946768 |
| 40 | Orchitis (HP:0100796) | 3.03572279 |
| 41 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.02866888 |
| 42 | Vasculitis (HP:0002633) | 3.00855852 |
| 43 | Keratoconjunctivitis sicca (HP:0001097) | 2.96812721 |
| 44 | Abnormality of T cell physiology (HP:0011840) | 2.94829103 |
| 45 | Mediastinal lymphadenopathy (HP:0100721) | 2.91614816 |
| 46 | Abnormality of the nasal mucosa (HP:0000433) | 2.83958204 |
| 47 | Leukocytosis (HP:0001974) | 2.79880036 |
| 48 | Spontaneous hematomas (HP:0007420) | 2.78566032 |
| 49 | Pulmonary infiltrates (HP:0002113) | 2.78420366 |
| 50 | Keratoconjunctivitis (HP:0001096) | 2.70746665 |
| 51 | Renal cortical cysts (HP:0000803) | 2.67515115 |
| 52 | Granulocytopenia (HP:0001913) | 2.65962464 |
| 53 | Hypoplasia of the thymus (HP:0000778) | 2.63645440 |
| 54 | Hemoptysis (HP:0002105) | 2.62207766 |
| 55 | Abnormality of the prostate (HP:0008775) | 2.61040437 |
| 56 | Pustule (HP:0200039) | 2.59712968 |
| 57 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.58158848 |
| 58 | Obstructive lung disease (HP:0006536) | 2.53434077 |
| 59 | Chronic obstructive pulmonary disease (HP:0006510) | 2.53434077 |
| 60 | Encephalitis (HP:0002383) | 2.53211806 |
| 61 | Recurrent sinusitis (HP:0011108) | 2.53048486 |
| 62 | Inflammation of the large intestine (HP:0002037) | 2.52448126 |
| 63 | Recurrent bacterial skin infections (HP:0005406) | 2.50866274 |
| 64 | Protruding tongue (HP:0010808) | 2.48955677 |
| 65 | Febrile seizures (HP:0002373) | 2.47061307 |
| 66 | Thrombocytosis (HP:0001894) | 2.45503012 |
| 67 | Truncal obesity (HP:0001956) | 2.45249071 |
| 68 | Chronic hepatic failure (HP:0100626) | 2.43839064 |
| 69 | Increased IgE level (HP:0003212) | 2.40975445 |
| 70 | Recurrent skin infections (HP:0001581) | 2.40921659 |
| 71 | Lymphoma (HP:0002665) | 2.40537283 |
| 72 | Abnormality of the renal cortex (HP:0011035) | 2.38865739 |
| 73 | Gastrointestinal inflammation (HP:0004386) | 2.38129748 |
| 74 | Arterial thrombosis (HP:0004420) | 2.36568523 |
| 75 | Acute myeloid leukemia (HP:0004808) | 2.26577801 |
| 76 | Alveolar cell carcinoma (HP:0006519) | 2.26034485 |
| 77 | Volvulus (HP:0002580) | 2.23792753 |
| 78 | Increased IgM level (HP:0003496) | 2.22576285 |
| 79 | Bronchitis (HP:0012387) | 2.21568549 |
| 80 | Progressive cerebellar ataxia (HP:0002073) | 2.20521728 |
| 81 | Papilloma (HP:0012740) | 2.16944917 |
| 82 | Verrucae (HP:0200043) | 2.16944917 |
| 83 | Joint swelling (HP:0001386) | 2.16294452 |
| 84 | Abnormality of the corticospinal tract (HP:0002492) | 2.16192841 |
| 85 | Progressive inability to walk (HP:0002505) | 2.15576347 |
| 86 | Cellulitis (HP:0100658) | 2.11546707 |
| 87 | Amyotrophic lateral sclerosis (HP:0007354) | 2.10666559 |
| 88 | Papilledema (HP:0001085) | 2.10637309 |
| 89 | Heterotopia (HP:0002282) | 2.09287195 |
| 90 | Colitis (HP:0002583) | 2.08619519 |
| 91 | Gaze-evoked nystagmus (HP:0000640) | 2.07791351 |
| 92 | Periodontitis (HP:0000704) | 2.07509304 |
| 93 | Chronic sinusitis (HP:0011109) | 2.05906128 |
| 94 | Chest pain (HP:0100749) | 2.04379071 |
| 95 | Fair hair (HP:0002286) | 2.04172221 |
| 96 | Prolonged bleeding time (HP:0003010) | 2.03252771 |
| 97 | Keratitis (HP:0000491) | 2.02201608 |
| 98 | Abnormal platelet volume (HP:0011876) | 2.01840040 |
| 99 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.00045007 |
| 100 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.00045007 |
| 101 | Menstrual irregularities (HP:0000858) | 1.99254810 |
| 102 | Excessive salivation (HP:0003781) | 1.94262911 |
| 103 | Persistence of primary teeth (HP:0006335) | 1.93262475 |
| 104 | Prominent nose (HP:0000448) | 1.92205851 |
| 105 | Ureteral obstruction (HP:0006000) | 1.91637291 |
| 106 | Absent frontal sinuses (HP:0002688) | 1.88970884 |
| 107 | Chromsome breakage (HP:0040012) | 1.87925250 |
| 108 | Hypergammaglobulinemia (HP:0010702) | 1.87182304 |
| 109 | Basal cell carcinoma (HP:0002671) | 1.86550773 |
| 110 | Tubulointerstitial nephritis (HP:0001970) | 1.85778396 |
| 111 | Slow saccadic eye movements (HP:0000514) | 1.84180845 |
| 112 | Gastrointestinal infarctions (HP:0005244) | 1.84068980 |
| 113 | Drooling (HP:0002307) | 1.84063481 |
| 114 | Epistaxis (HP:0000421) | 1.83616359 |
| 115 | Long eyelashes (HP:0000527) | 1.82652445 |
| 116 | Lip pit (HP:0100267) | 1.81285321 |
| 117 | Pulmonary embolism (HP:0002204) | 1.81185897 |
| 118 | Cheilitis (HP:0100825) | 1.80805590 |
| 119 | Viral hepatitis (HP:0006562) | 1.80602443 |
| 120 | Recurrent otitis media (HP:0000403) | 1.80030432 |
| 121 | Ureteral stenosis (HP:0000071) | 1.79776986 |
| 122 | Gingivitis (HP:0000230) | 1.79267653 |
| 123 | Abnormal hair whorl (HP:0010721) | 1.77436562 |
| 124 | Gastrointestinal stroma tumor (HP:0100723) | 1.77209271 |
| 125 | Abnormality of the pleura (HP:0002103) | 1.76839291 |
| 126 | Osteomyelitis (HP:0002754) | 1.76491270 |
| 127 | Postural instability (HP:0002172) | 1.76452213 |
| 128 | Widely spaced teeth (HP:0000687) | 1.76238377 |
| 129 | Abnormality of the columella (HP:0009929) | 1.76039706 |
| 130 | Bronchiectasis (HP:0002110) | 1.73216721 |
| 131 | Abnormality of chromosome stability (HP:0003220) | 1.71965149 |
| 132 | Anhidrosis (HP:0000970) | 1.70673972 |
| 133 | Papillary thyroid carcinoma (HP:0002895) | 1.68866238 |
| 134 | Sandal gap (HP:0001852) | 1.67138381 |
| 135 | Hypoplastic iliac wings (HP:0002866) | 1.65904177 |
| 136 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.65081145 |
| 137 | Clumsiness (HP:0002312) | 1.64583893 |
| 138 | Acute hepatic failure (HP:0006554) | 1.64420891 |
| 139 | Generalized hypopigmentation of hair (HP:0011358) | 1.64001839 |
| 140 | Atonic seizures (HP:0010819) | 1.63022446 |
| 141 | Hyperventilation (HP:0002883) | 1.62887043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.75506236 |
| 2 | MAP4K1 | 4.87733276 |
| 3 | JAK3 | 2.84649938 |
| 4 | ITK | 2.78643623 |
| 5 | MAP3K14 | 2.72951393 |
| 6 | CAMKK2 | 2.57713940 |
| 7 | CDK12 | 2.55167952 |
| 8 | STK10 | 2.46905065 |
| 9 | ZAP70 | 2.44183744 |
| 10 | TYK2 | 2.38359445 |
| 11 | IKBKE | 2.34506618 |
| 12 | FGFR3 | 2.20133496 |
| 13 | TEC | 2.11236851 |
| 14 | JAK1 | 2.09420434 |
| 15 | FGFR4 | 1.99877066 |
| 16 | NLK | 1.98557889 |
| 17 | IRAK4 | 1.91531296 |
| 18 | GRK6 | 1.86156579 |
| 19 | CLK1 | 1.75225355 |
| 20 | AKT3 | 1.60072317 |
| 21 | LCK | 1.59359435 |
| 22 | CSK | 1.58075942 |
| 23 | BTK | 1.55173177 |
| 24 | EEF2K | 1.53042512 |
| 25 | SYK | 1.49996875 |
| 26 | HCK | 1.45569083 |
| 27 | IKBKB | 1.40223040 |
| 28 | CHUK | 1.39608951 |
| 29 | ACVR1B | 1.39290669 |
| 30 | BMPR2 | 1.38541544 |
| 31 | MAP3K4 | 1.33514492 |
| 32 | PIM1 | 1.31360756 |
| 33 | EPHA3 | 1.30656709 |
| 34 | TGFBR2 | 1.29085074 |
| 35 | MAP3K13 | 1.28982133 |
| 36 | TBK1 | 1.26532445 |
| 37 | CAMKK1 | 1.25631448 |
| 38 | MAP3K10 | 1.23223929 |
| 39 | MARK3 | 1.20037797 |
| 40 | NUAK1 | 1.17612235 |
| 41 | NEK6 | 1.16284914 |
| 42 | ERBB3 | 1.15294123 |
| 43 | WNK1 | 1.12435948 |
| 44 | TNIK | 1.11332231 |
| 45 | PRKCQ | 1.09823398 |
| 46 | MAP4K2 | 1.09394415 |
| 47 | PASK | 1.05676782 |
| 48 | PIK3CG | 1.03761091 |
| 49 | SGK223 | 1.00089660 |
| 50 | SGK494 | 1.00089660 |
| 51 | RPS6KA4 | 0.99953851 |
| 52 | KIT | 0.99739457 |
| 53 | BRD4 | 0.97056387 |
| 54 | TNK2 | 0.94515890 |
| 55 | SIK2 | 0.94264195 |
| 56 | BMPR1B | 0.92772991 |
| 57 | STK4 | 0.91918735 |
| 58 | MAP2K3 | 0.91283737 |
| 59 | FES | 0.89878648 |
| 60 | CAMK4 | 0.86715948 |
| 61 | MAPK13 | 0.86454121 |
| 62 | CDK9 | 0.85927205 |
| 63 | SIK3 | 0.83219455 |
| 64 | TRPM7 | 0.81835092 |
| 65 | PRKCH | 0.81670075 |
| 66 | SGK3 | 0.80697594 |
| 67 | LYN | 0.79919049 |
| 68 | BCR | 0.79120385 |
| 69 | CSF1R | 0.78595896 |
| 70 | JAK2 | 0.74935055 |
| 71 | MAP3K7 | 0.74277801 |
| 72 | STK38 | 0.73872836 |
| 73 | INSRR | 0.72031998 |
| 74 | ATR | 0.71540068 |
| 75 | MELK | 0.71155065 |
| 76 | CDK6 | 0.70983139 |
| 77 | CDK4 | 0.70786352 |
| 78 | YES1 | 0.70516830 |
| 79 | TYRO3 | 0.69581263 |
| 80 | PIK3CA | 0.69295535 |
| 81 | SGK2 | 0.68886798 |
| 82 | DYRK1A | 0.68163721 |
| 83 | MARK2 | 0.67311553 |
| 84 | STK24 | 0.65143510 |
| 85 | CDC7 | 0.63200150 |
| 86 | LRRK2 | 0.63003344 |
| 87 | MST4 | 0.62905486 |
| 88 | NTRK2 | 0.61225758 |
| 89 | SGK1 | 0.60055268 |
| 90 | PAK3 | 0.59549235 |
| 91 | MKNK2 | 0.58683267 |
| 92 | EGFR | 0.57928393 |
| 93 | TLK1 | 0.57560831 |
| 94 | BLK | 0.56869865 |
| 95 | EIF2AK3 | 0.56403935 |
| 96 | MAP2K7 | 0.55899188 |
| 97 | RIPK4 | 0.55132647 |
| 98 | RAF1 | 0.53915556 |
| 99 | CAMK1G | 0.53836619 |
| 100 | FRK | 0.53378381 |
| 101 | PRPF4B | 0.53078248 |
| 102 | TGFBR1 | 0.52752366 |
| 103 | RPS6KA5 | 0.52500423 |
| 104 | PTK2B | 0.52206007 |
| 105 | STK11 | 0.51188508 |
| 106 | TAOK3 | 0.49430852 |
| 107 | RET | 0.49363343 |
| 108 | IGF1R | 0.48574806 |
| 109 | RPS6KB1 | 0.48067176 |
| 110 | ADRBK2 | 0.48006242 |
| 111 | MAPK7 | 0.47811082 |
| 112 | MAPK11 | 0.46453528 |
| 113 | HIPK2 | 0.46368568 |
| 114 | SRPK1 | 0.46220555 |
| 115 | CDK3 | 0.46089799 |
| 116 | MARK1 | 0.45782301 |
| 117 | ZAK | 0.45649596 |
| 118 | TTN | 0.44654453 |
| 119 | FGR | 0.43226757 |
| 120 | ATM | 0.42344874 |
| 121 | CAMK1D | 0.41031053 |
| 122 | RPS6KB2 | 0.40453257 |
| 123 | CASK | 0.39746532 |
| 124 | PINK1 | 0.39679830 |
| 125 | DMPK | 0.39441588 |
| 126 | EPHB1 | 0.39066981 |
| 127 | INSR | 0.37502911 |
| 128 | PDGFRB | 0.36894199 |
| 129 | FGFR2 | 0.36450564 |
| 130 | CHEK1 | 0.35374620 |
| 131 | IRAK1 | 0.34418348 |
| 132 | MAP3K12 | 0.34356457 |
| 133 | PRKD2 | 0.32325063 |
| 134 | PRKAA2 | 0.31136148 |
| 135 | KDR | 0.29641568 |
| 136 | EIF2AK2 | 0.27699995 |
| 137 | PDK1 | 0.27594999 |
| 138 | ALK | 0.26174813 |
| 139 | ABL1 | 0.25466276 |
| 140 | MAPKAPK2 | 0.25172935 |
| 141 | MKNK1 | 0.25043345 |
| 142 | MAP2K6 | 0.25013272 |
| 143 | MAPK3 | 0.24176567 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.21549205 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.87348950 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.70066943 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.58833661 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.55633143 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.55184291 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.34509885 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.22266403 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.19051634 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.13180411 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.02916609 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.99141339 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.93101077 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.91802245 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.83755773 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.68040684 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.62853678 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.61413280 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.55844304 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.51015338 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40005525 |
| 22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.38742118 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.33324879 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32457945 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.29315944 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.28385812 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.27182592 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.26570114 |
| 29 | Hepatitis B_Homo sapiens_hsa05161 | 1.23986813 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22785331 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20264187 |
| 32 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.18603919 |
| 33 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.15429798 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15305687 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14309788 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.10025958 |
| 37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08529847 |
| 38 | HTLV-I infection_Homo sapiens_hsa05166 | 1.07106752 |
| 39 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.05321368 |
| 40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.03744956 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.02186326 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00026296 |
| 43 | Nicotine addiction_Homo sapiens_hsa05033 | 0.98602556 |
| 44 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.97599043 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 0.95435786 |
| 46 | Circadian rhythm_Homo sapiens_hsa04710 | 0.95336113 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 0.94589057 |
| 48 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93819173 |
| 49 | Tuberculosis_Homo sapiens_hsa05152 | 0.89644098 |
| 50 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.88216388 |
| 51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87800840 |
| 52 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.87535577 |
| 53 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.87286600 |
| 54 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.87216340 |
| 55 | Taste transduction_Homo sapiens_hsa04742 | 0.86638016 |
| 56 | Morphine addiction_Homo sapiens_hsa05032 | 0.86509108 |
| 57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85155722 |
| 58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84332807 |
| 59 | Long-term potentiation_Homo sapiens_hsa04720 | 0.84264466 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83772930 |
| 61 | Basal transcription factors_Homo sapiens_hsa03022 | 0.83575948 |
| 62 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83572272 |
| 63 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.82490460 |
| 64 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.81888309 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.80296111 |
| 66 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.79140412 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 0.77954438 |
| 68 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76907581 |
| 69 | Malaria_Homo sapiens_hsa05144 | 0.76902059 |
| 70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.74405889 |
| 71 | Adherens junction_Homo sapiens_hsa04520 | 0.72297504 |
| 72 | Legionellosis_Homo sapiens_hsa05134 | 0.71982147 |
| 73 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71673844 |
| 74 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.71320593 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70553216 |
| 76 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.70177040 |
| 77 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.69835413 |
| 78 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68641079 |
| 79 | Pertussis_Homo sapiens_hsa05133 | 0.67623919 |
| 80 | RNA degradation_Homo sapiens_hsa03018 | 0.67345677 |
| 81 | Salmonella infection_Homo sapiens_hsa05132 | 0.65998895 |
| 82 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.65363295 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65320049 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64974726 |
| 85 | Glioma_Homo sapiens_hsa05214 | 0.64588112 |
| 86 | Olfactory transduction_Homo sapiens_hsa04740 | 0.62070510 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61786510 |
| 88 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.61216167 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59838301 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59522820 |
| 91 | Base excision repair_Homo sapiens_hsa03410 | 0.59214287 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58713247 |
| 93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58144282 |
| 94 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.57512837 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56859933 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55387913 |
| 97 | Cell cycle_Homo sapiens_hsa04110 | 0.55013577 |
| 98 | DNA replication_Homo sapiens_hsa03030 | 0.54949276 |
| 99 | Homologous recombination_Homo sapiens_hsa03440 | 0.54753438 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54574757 |
| 101 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54283506 |
| 102 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.54238242 |
| 103 | Phototransduction_Homo sapiens_hsa04744 | 0.53588155 |
| 104 | Spliceosome_Homo sapiens_hsa03040 | 0.52861023 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52495489 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52230835 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.52156352 |
| 108 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51781022 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50287233 |
| 110 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.48838522 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48762595 |
| 112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46281909 |
| 113 | Lysine degradation_Homo sapiens_hsa00310 | 0.44586453 |
| 114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44228554 |
| 115 | Mismatch repair_Homo sapiens_hsa03430 | 0.42702088 |
| 116 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42129790 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41240712 |
| 118 | Pathways in cancer_Homo sapiens_hsa05200 | 0.40772162 |
| 119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40487006 |
| 120 | ABC transporters_Homo sapiens_hsa02010 | 0.38850001 |
| 121 | Thyroid cancer_Homo sapiens_hsa05216 | 0.38185490 |
| 122 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.37450126 |
| 123 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37237679 |
| 124 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.37018277 |
| 125 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34677944 |
| 126 | RNA transport_Homo sapiens_hsa03013 | 0.33661163 |
| 127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32764014 |
| 128 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32452233 |
| 129 | Insulin resistance_Homo sapiens_hsa04931 | 0.31416172 |
| 130 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31302301 |

